For a patient using estradiol valerate in a 5 mL vial, what is the typical number of days the supply will last?

Day Supply for Estradiol Valerate 5 mL Vial

For injectable estradiol valerate, a 5 mL vial typically provides a 25-50 day supply, depending on the prescribed dose, with most patients using 3-5 mg weekly.

Dosing Context and Supply Calculation

The day supply calculation depends critically on the prescribed weekly dose. Based on FDA labeling and recent clinical evidence, injectable estradiol valerate dosing varies significantly by indication:

Standard Dosing Ranges

For gender-affirming hormone therapy:

• Current evidence strongly suggests 3-5 mg weekly as the appropriate starting and maintenance dose 1, 2, 3
• Recent retrospective data demonstrates that 78.3% of patients on 3 mg weekly and 76.0% on 4 mg weekly achieve physiologic estradiol levels (100-357 pg/mL) 1
• Higher doses (>5 mg weekly) consistently produce supraphysiologic levels and should be avoided 2, 3

For menopausal hormone therapy:

• Intramuscular dosing: 4 mg provides therapeutic effect for 2-4 weeks (depot effect) 4
• This translates to approximately 2-4 mg every 2-4 weeks for this indication

Calculating Day Supply

Assuming standard vial concentrations (typically 20-40 mg/mL):

For a 20 mg/mL concentration (100 mg total in 5 mL):

• At 5 mg weekly: 100 mg ÷ 5 mg = 20 weeks = 140 days
• At 4 mg weekly: 100 mg ÷ 4 mg = 25 weeks = 175 days
• At 3 mg weekly: 100 mg ÷ 3 mg = 33 weeks = 231 days

For a 40 mg/mL concentration (200 mg total in 5 mL):

• At 5 mg weekly: 200 mg ÷ 5 mg = 40 weeks = 280 days
• At 4 mg weekly: 200 mg ÷ 4 mg = 50 weeks = 350 days

Critical Considerations

Common Pitfall: Outdated Dosing Guidelines

The Endocrine Society guidelines suggest 2-10 mg weekly or 5-30 mg every 2 weeks 2, 3, but recent evidence demonstrates these recommendations are too high. Multiple studies from 2024-2026 show that doses at the higher end of these ranges produce supraphysiologic estradiol levels 1, 2, 3.

Practical Approach

1. Verify the vial concentration (mg/mL) - this is essential for accurate calculation
2. Confirm the prescribed weekly dose - should typically be ≤5 mg weekly
3. Calculate total mg in vial (concentration × 5 mL)
4. Divide by weekly dose to get number of weeks
5. Multiply by 7 to convert to days

Route Considerations

Both subcutaneous and intramuscular routes are effective, with no clinically significant differences in pharmacokinetics for day supply calculations 2. The FDA labeling confirms estradiol valerate is cleaved to 17β-estradiol during absorption regardless of route 5.

Monitoring Note

Blood draws should ideally occur mid-cycle between injections to assess trough levels, as peak levels occur approximately 2-4 days post-injection 6. This timing consideration doesn't affect day supply calculation but is crucial for dose adjustment.